Discontinued — last reported Q4 '23
Thermo Fisher Scientific All Other Countries — Long-Lived Assets increased by 1.9% to $4.65B in Q4 2023 compared to the prior quarter.
An increase suggests capital expansion or infrastructure investment in secondary markets, while a decrease may indicate asset divestiture or a shift in geographic strategy.
This metric represents the total book value of non-current, tangible, and intangible assets held by the company in geogr...
Peers in the life sciences and diagnostics sector typically report similar geographic asset splits, often categorized by region or as 'Rest of World' to reflect global supply chain and service footprints.
tmo_segment_other_long_lived_assets| Q4 '21 | Q4 '22 | Q4 '23 | |
|---|---|---|---|
| Value | $4.29B | $4.57B | $4.65B |
| QoQ Change | — | +6.5% | +1.9% |
| YoY Change | — | +6.5% | +1.9% |